[go: up one dir, main page]

ES2065478T3 - 2-amino-1,2,3,4-tetrahidronaftalenos y 3-aminocromanos sustituidos en el anillo. - Google Patents

2-amino-1,2,3,4-tetrahidronaftalenos y 3-aminocromanos sustituidos en el anillo.

Info

Publication number
ES2065478T3
ES2065478T3 ES90301901T ES90301901T ES2065478T3 ES 2065478 T3 ES2065478 T3 ES 2065478T3 ES 90301901 T ES90301901 T ES 90301901T ES 90301901 T ES90301901 T ES 90301901T ES 2065478 T3 ES2065478 T3 ES 2065478T3
Authority
ES
Spain
Prior art keywords
alkyl
substituted
aryl
amino
ring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90301901T
Other languages
English (en)
Inventor
Michael Edward Flaugh
John Mehnert Schaus
Robert Daniel Titus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2065478T3 publication Critical patent/ES2065478T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • C07C317/36Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/38Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with the sulfur atom of the thio group bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

EL PRESENTE INVENTO SUMINISTRAN ACTIVIDAD ENLAZANTE AL RECEPTOR 1A DE LA SEROTONINA E INTERMEDIARIOS DE 3-AMINOCROMANO. LOS COMPUESTOS FARMACEUTICOS TIENEN LA FORMULA (I) EN LA CUAL R1 ES UN ALKIL C1-C4, ALIL, O CICLOPROPILMETIL; R1 ES HIDROGENO, ALKIL C1-C4, ALIL, CICLOPROPILMETIL O ARIL (C1-C4-ALKIL); R2 ES HIDROGENO O METIL; X ES -CH2- O -O-; R3 ES ALKIL C1-C8, ARIL, ARIL SUSTITUIDO, ARIL (C1-C4-ALKIL), ARIL SUSTITUIDO (ALKIL C1-C4), O CICLOALKIL C5-C7; N ES 0, 1 O 2; Y LAS SALES DE ADICCION ACIDAS FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS.
ES90301901T 1989-02-27 1990-02-22 2-amino-1,2,3,4-tetrahidronaftalenos y 3-aminocromanos sustituidos en el anillo. Expired - Lifetime ES2065478T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31575289A 1989-02-27 1989-02-27

Publications (1)

Publication Number Publication Date
ES2065478T3 true ES2065478T3 (es) 1995-02-16

Family

ID=23225899

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90301901T Expired - Lifetime ES2065478T3 (es) 1989-02-27 1990-02-22 2-amino-1,2,3,4-tetrahidronaftalenos y 3-aminocromanos sustituidos en el anillo.

Country Status (21)

Country Link
US (1) US5637624A (es)
EP (1) EP0385658B1 (es)
JP (2) JP2954255B2 (es)
KR (1) KR900012890A (es)
CN (2) CN1031262C (es)
AT (1) ATE116289T1 (es)
AU (1) AU630671B2 (es)
CA (2) CA2362972A1 (es)
DE (1) DE69015384T2 (es)
DK (1) DK0385658T3 (es)
ES (1) ES2065478T3 (es)
GR (1) GR3015136T3 (es)
HU (2) HU209481B (es)
IE (1) IE65769B1 (es)
IL (5) IL93464A (es)
MX (1) MX19637A (es)
NZ (1) NZ232628A (es)
PH (1) PH27444A (es)
PT (1) PT93218B (es)
RU (1) RU1826966C (es)
ZA (1) ZA901277B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
CA2047236C (en) * 1989-04-27 1997-07-22 Bengt Ronny Andersson Substituted 3-amino chromans
US5616610A (en) * 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
CA2048846A1 (en) * 1990-08-15 1992-02-16 Craig Steven Hoechstetter Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes, 3-aminochromanes, and aminothiochromanes
ES2041211B1 (es) * 1992-02-17 1994-05-16 Uriach & Cia Sa J Procedimiento para la obtencion de nuevos dihidro y tetrahidronaftalenos.
SE9301732D0 (sv) * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
GB9514417D0 (en) * 1995-07-14 1995-09-13 Iaf Biochem Int Novel heterocyclic compounds for the treatment of pain and use thereof
SK180499A3 (en) 1997-07-01 2001-08-06 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
FR2792529B1 (fr) * 1999-04-26 2001-09-28 Sod Conseils Rech Applic Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
WO2005037830A1 (en) * 2003-10-10 2005-04-28 Wyeth Piperidinylchromen-6-ylsulfonamide compounds as 5-hydroxytryptamine-6 ligands
AU2005318596B2 (en) * 2004-12-21 2010-12-23 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-HT receptor ligands
ATE499355T1 (de) * 2005-11-03 2011-03-15 Hoffmann La Roche Arylsulfonylchromane als 5-ht6-inhibitoren
EP2098511A1 (en) 2008-03-07 2009-09-09 Solvias AG Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring
EP2338873A1 (en) 2009-12-22 2011-06-29 Gmeiner, Peter New aminotetraline derivatives

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3253037A (en) * 1962-06-19 1966-05-24 Ciba Geigy Corp N-2-alkynyl-amino-benzocylo-alkanes
GB1037014A (en) * 1963-08-02 1966-07-20 Aspro Nicholas Ltd Derivatives of 1-aminoindane
US3709996A (en) * 1963-08-02 1973-01-09 Aspro Nicholas Ltd Pharmaceutical compositions containing n-cyclopropyl-1-aminoindane compounds and adapted for administration to obtain inhibition of monoamine oxidase enzyme and process
US3637740A (en) * 1969-04-21 1972-01-25 Pfizer Aminobenzocycloalkane compounds
US3758640A (en) * 1970-07-20 1973-09-11 Hooker Chemical Corp Opolymer and a polyester polymer composition comprising vinylmonomer butadiene polymer graft c
US3929891A (en) * 1971-02-08 1975-12-30 Hoechst Ag Reduction of halonitroaromates using sulfited platinum on carbon catalysts
SE8004002L (sv) * 1980-05-29 1981-11-30 Arvidsson Folke Lars Erik Terapeutiskt anvendbara tetralinderivat
US4320148A (en) * 1980-11-24 1982-03-16 Smithkline Corporation 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
WO1987002035A1 (en) * 1985-10-04 1987-04-09 Maggioni-Winthrop S.P.A. Fused cycloaliphatic aminoalcohols
SE8605504D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel chroman derivatives
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
CA1331191C (en) * 1988-03-25 1994-08-02 Bengt Ronny Andersson Therapeutically useful tetralin derivatives
AU4844290A (en) * 1989-01-09 1990-08-01 Upjohn Company, The Halo substituted aminotetralins
JP2885317B2 (ja) * 1989-01-31 1999-04-19 三菱化学株式会社 耐衝撃熱可塑性樹脂組成物の製造方法

Also Published As

Publication number Publication date
HU901048D0 (en) 1990-05-28
KR900012890A (ko) 1990-09-03
IE65769B1 (en) 1995-11-15
JPH02268151A (ja) 1990-11-01
CN1031262C (zh) 1996-03-13
HUT65268A (en) 1994-05-02
JPH11315063A (ja) 1999-11-16
PH27444A (en) 1993-07-02
CN1051990C (zh) 2000-05-03
CA2010542A1 (en) 1990-08-27
HU209481B (en) 1994-06-28
IL93464A (en) 1996-10-16
IE900684L (en) 1990-08-27
EP0385658B1 (en) 1994-12-28
PT93218B (pt) 1996-03-29
AU630671B2 (en) 1992-11-05
DK0385658T3 (da) 1995-02-20
US5637624A (en) 1997-06-10
HU221625B1 (hu) 2002-12-28
RU1826966C (ru) 1993-07-07
HUT53354A (en) 1990-10-28
CA2010542C (en) 2002-05-14
EP0385658A1 (en) 1990-09-05
CA2362972A1 (en) 1990-08-27
IL114715A (en) 1997-01-10
ATE116289T1 (de) 1995-01-15
JP2954255B2 (ja) 1999-09-27
MX19637A (es) 1994-02-28
PT93218A (pt) 1990-08-31
IL109647A (en) 1997-04-15
DE69015384D1 (de) 1995-02-09
DE69015384T2 (de) 1995-05-18
HU9202449D0 (en) 1992-12-28
IL114715A0 (en) 1995-11-27
IL93464A0 (en) 1990-11-29
AU5014490A (en) 1990-10-25
JP3000016B2 (ja) 2000-01-17
NZ232628A (en) 1992-03-26
GR3015136T3 (en) 1995-05-31
CN1045099A (zh) 1990-09-05
ZA901277B (en) 1991-10-30
CN1120532A (zh) 1996-04-17
IL109647A0 (en) 1994-08-26

Similar Documents

Publication Publication Date Title
ES2065478T3 (es) 2-amino-1,2,3,4-tetrahidronaftalenos y 3-aminocromanos sustituidos en el anillo.
DE69331843D1 (de) Xanthine-Derivate als Antidepressiva
ES2132284T3 (es) Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa.
DK0471515T3 (da) Ringsubstituerede 2-amino-1,2,3,4-tetrahydronphtalener, 3-aminochromaner og 3-aminothiochromaner
MY116454A (en) Ring-substituted 2-amino-1, 2,3,4-tetra- hydronaphthalenes and 3-aminochromanes.
PT93687A (pt) Processo para a preparacao de antagonistas de serotonina de tetra-hidrobenz,d}indole
ID23954A (id) Tetrahidrogama-karbolin
DE3880022D1 (de) Cycloalkylamide von (8beta)-1-alkyl-6-(substituierten) ergolinen.
DE69010285D1 (de) Als Spasmolytica geeignete Dibenzothiazepin-Derivate.
FI95247C (fi) Menetelmä lääkeaineina käytettävien 1,3-tiatsolidinien -karbonyylikarboksiamidien valmistamiseksi
MX25858A (es) 3-[1-tiazolidinilbutil-4-piperazinil]-1h-indazolesun procedimiento para su preparacion y su uso comomedicamentos.
RU93005087A (ru) 3-(тиазолидинилбутил-4-пиперазинил)-ih-индазолы
ATE246682T1 (de) Benzothiazinderivate
ES2111086T3 (es) Compuestos triciclicos anfoteros como agentes antihistaminicos y antialergicos.
DK0417746T3 (da) N-Azabicyclo(3.3.0)octanamider af aromatiske syrer
DE68914211D1 (de) Verfahren zur Herstellung von Zwischenprodukten in der Synthese von Diltiazem.
EP1325913A3 (en) Piperidinecarboxylic acid amide derivatives
IL80525A (en) Preparation of indolines by cyclodehydrating 2-(2'-aminoethylphenyl)-ethanol in the presence of amorphous aluminium silicate catalyst

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 385658

Country of ref document: ES